FT Options’s Aegerion Pharmaceuticals AEGR Stock Holding History

FT Options’s Portfolio AEGR Stock Details AEGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-36,000	Closed	-$1K	–	436
2016 Q3	$1K	Hold	36,000	–	–	﹤0.01%	361
2016 Q2	$1K	Sell	36,000 -31,900	-47%	-$73K	﹤0.01%	340
2016 Q1	$5K	Hold	67,900	–	–	0.01%	272
2015 Q4	$132K	Buy	+67,900	New	+$817K	0.1%	122

FT Options's AEGR Position: Q2 2016 in Review

FT Options sold out of Aegerion Pharmaceuticals (AEGR) in Q2 2016, closing a stake of 16,345 shares — an estimated $37.4K sold.

FT Options first reported a position in AEGR in Q4 2015 and held it in 2 quarters. The position peaked at $590K in Q4 2015. 71 funds tracked by Wall St. Rank hold AEGR as of Q2 2016.

FT Options reported no remaining Aegerion Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
FT Options sold 16,345 Aegerion Pharmaceuticals shares in Q2 2016, an estimated $37.4K.
FT Options first reported a position in Aegerion Pharmaceuticals in Q4 2015 and held it in 2 quarters.
FT Options's Aegerion Pharmaceuticals position peaked at $590K in Q4 2015.
71 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q2 2016.

Based on FT Options's 13F filing for Q2 2016, filed 12 Aug 2016.